We are live on ! Find out more
FCSC

Fibrocell Science Inc.
FCSC

Delisted

FCSC was delisted on the 12th of December, 2019.

39 hedge funds and large institutions have $120M invested in Fibrocell Science Inc. in 2015 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 10 increasing their positions, 6 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

117% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 6

79% more capital invested

Capital invested by funds: $66.9M → $120M (+$52.6M)

67% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 6

22% more funds holding

Funds holding: 3239 (+7)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

Holders
39
Holders Change
+7
Holders Change %
+21.88%
% of All Funds
1.04%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
13
Increased
10
Reduced
6
Closed
6
Calls
$2K
Puts
Net Calls
+$2K
Net Calls Change
+$2K
Name Holding Trade Value Shares
Change
Change in
Stake
TS
1
Third Security
Virginia
$70.6M
Fidelity Investments
2
Fidelity Investments
Massachusetts
$16.3M
Jennison Associates
3
Jennison Associates
New York
$11.9M -$180K -2,798 -2%
MP
4
MSD Partners
New York
$7.79M
Vanguard Group
5
Vanguard Group
Pennsylvania
$2.65M +$195K +3,030 +8%
CCA
6
Catalyst Capital Advisors
New York
$1.98M -$85.9K -1,333 -4%
EA
7
Emerald Advisers
Pennsylvania
$852K +$1.05M +16,278 New
Geode Capital Management
8
Geode Capital Management
Massachusetts
$775K +$78.4K +1,217 +12%
HVC
9
Healthcare Value Capital
New Jersey
$712K
TMC
10
Trellus Management Company
Florida
$518K -$38.3K -594 -7%
BGA
11
Belmont Global Advisors
Texas
$498K +$474K +7,365 New
Bank of New York Mellon
12
Bank of New York Mellon
New York
$447K
SIP
13
Stoneridge Investment Partners
Pennsylvania
$442K +$12.1K +188 +3%
Goldman Sachs
14
Goldman Sachs
New York
$416K +$71.1K +1,104 +22%
California Public Employees Retirement System
15
California Public Employees Retirement System
California
$352K
SC
16
Saiers Capital
New York
$319K
BFA
17
BlackRock Fund Advisors
California
$304K -$19.6K -304 -6%
PAM
18
Panagora Asset Management
Massachusetts
$299K +$284K +4,415 New
Citigroup
19
Citigroup
New York
$263K -$104K -1,615 -29%
Millennium Management
20
Millennium Management
New York
$252K +$171K +2,662 +250%
EEG
21
E.E. Geduld
$226K +$150K +2,333 +233%
Northern Trust
22
Northern Trust
Illinois
$200K -$129K -2,000 -40%
New York State Common Retirement Fund
23
New York State Common Retirement Fund
New York
$193K +$184K +2,858 New
CS
24
Credit Suisse
Switzerland
$192K +$183K +2,834 New
CCM
25
Context Capital Management
California
$158K +$107K +1,668 +248%

FCSC Hedge Fund Activity: Q1 2015 in Review

39 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Fibrocell Science Inc. (FCSC) for Q1 2015, worth a combined $120M — up 79% from $66.9M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new FCSC positions and 6 closed out — a net gain of 7 holders — while 10 added to existing stakes and 6 trimmed.

The largest buyer was Emerald Advisers, opening a new position worth an estimated $1.05M. The largest seller was Jennison Associates, cutting an estimated $180K.

  • 39 institutional investors held Fibrocell Science Inc. (FCSC) as of Q1 2015, up from 32 in Q4 2014.
  • Funds reported $120M of Fibrocell Science Inc. stock for Q1 2015, up 79% quarter-over-quarter.
  • 13 funds opened new Fibrocell Science Inc. positions in Q1 2015 and 6 closed out, a net change of +7 holders.
  • The largest Fibrocell Science Inc. buyer in Q1 2015 was Emerald Advisers, an estimated $1.05M added.
  • The largest Fibrocell Science Inc. seller in Q1 2015 was Jennison Associates, an estimated $180K sold.

Based on aggregated 13F filings for Q1 2015.